Colonoscopy is the most commonly performed endoscopic procedure and overall is considered a low-risk procedure. However, adverse events (AEs) related to this routinely performed procedure for screening, diagnostic, or therapeutic purposes are an important clinical consideration. The purpose of this document from the American Society for Gastrointestinal Endoscopy's Standards of Practice Committee is to provide an update on estimates of AEs related to colonoscopy in an evidence-based fashion. A systematic review and meta-analysis of populationbased studies was conducted for the 3 most common and important serious AEs (bleeding, perforation, and mortality). In addition, this document includes an updated systematic review and meta-analysis of serious AEs (bleeding and perforation) related to EMR and endoscopic submucosal dissection for large colon polyps. Finally, a narrative review of other colonoscopy-related serious AEs and those related to specific colonic interventions is included. (Gastrointest Endosc 2019;90:863-76.)
Colonoscopy is a commonly performed endoscopic procedure for various GI conditions and most routinely for the screening and surveillance of colorectal neoplasia. Overall, colonoscopy is considered a safe procedure, although a number of serious adverse events (AEs) have been reported. The definition of serious AEs is variable across studies but generally includes AEs that lead to an unplanned hospitalization, unplanned procedures or interventions, prolongation of an existing hospitalization, or death. Examples include bleeding, perforation, postpolypectomy syndrome, and cardiopulmonary AEs related to moderate or deep sedation.
Few population-based colonoscopy registries provide the exact magnitude of AEs associated with colonoscopy. Estimates of AEs related to colonoscopy in various studies differ by indications, patient population, asymptomatic versus symptomatic individuals, length, and completeness of follow-up after the procedure. In a 2008 systematic review of 12 studies totaling 57,742 colonoscopies performed for average-risk screening, the pooled overall AE rate was 2.8 per 1000 procedures (95% confidence interval [CI], 1.5-5.2), 1 whereas the reported incidence of AEs from mostly diagnostic colonoscopies performed in an integrated healthcare system in the United States was 5 per 1000 procedures (95% CI, 4.0-6.2). 2 In a 2016 evidence synthesis report by the Agency for Healthcare Research and Policy, the authors reported a pooled rate of major bleeding (22 studies; n Z 3,347,101) of .8 per 1000 procedures (95% CI, .5-1.4) and rate of perforation of .4 per 1000 procedures (95% CI, .2-.5) for screening colonoscopy. 3 Although the risk of AEs in most studies are often not stratified by whether or not polypectomy was performed, according to 1 study, 85% of AEs are reported in patients undergoing colonoscopy with polypectomy. 1 With the widespread application of advanced endoscopic techniques for removal of colorectal polyps, including EMR and endoscopic submucosal dissection (ESD), the AEs associated with these advanced techniques are highly relevant.
The aims of this document are to provide evidencebased estimates of the 3 most common and important AEs of colonoscopy (bleeding, perforation, and mortality) from population-based studies, to provide evidencebased estimates of AEs related to EMR and ESD (bleeding and perforation) for large colon polyps, and to provide a narrative-based review of aspiration, splenic injury, and less common AEs. A narrative update of the previous Standards of Practice document 4 on other AEs, such as postpolypectomy syndrome, infection, and gas bloating, is addressed in this document. Risk of AEs as they relate to sedation and the pediatric population are also discussed. Details of various bowel preparations and their respective AEs are discussed in a separate American Society for Gastrointestinal Endoscopy (ASGE) document. 5 
METHODS

Panel composition and conflict of interest management
The panel was composed of 2 primary authors (S.T.K., R.J.H.), a content expert (A.S.), committee chair (S.W.), and members of the Standards of Practice Committee. All panel members disclosed possible intellectual and financial conflicts of interest in concordance with ASGE policies (https://www.asge.org/docs/default-source/about-asge/ mission-and-governance/asge-conflict-of-interest-anddisclosure-policy.pdf).
Selection criteria
A search for population-level studies that provided estimates for the major postprocedural endpoints of perforation, bleeding, and mortality was conducted by a professional librarian using Ovid MEDLINE: Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE 1946 to present, Embase Classi-cþEmbase 1947 to January 2018, and Wiley Cochrane. In cases of multiple studies from the same group using the same data source (such as a conference proceeding followed by a manuscript), we included only the more recent and extensive of the studies.
Only studies published in English were included for analysis. We included both retrospective and prospective cohort studies with data collected between January 2001 and March 2017 in the study. Prespecified medical subject headings, non-medical subject heading terms, and the search algorithm are shown in Appendix 1 (available online at www.giejournal.org). For estimates of perforation and bleeding after EMR and ESD, we chose case series and comparative trials published between January 2008 and January 2018; this decision was made given the rapid changes in advanced mucosal/submucosal resection techniques within the last decade. We adopted a search algorithm derived from Hassan et al, 6 which is available in Appendix 2 (available online at www. giejournal.org). For EMR, we restricted our analysis to polyps !20 mm in size.
Two reviewers (S.T.K. and R.J.H.) independently screened all abstracts. Case reports, review articles, costeffectiveness or modeling studies, and animal studies were excluded. The full text of the remaining articles was evaluated to determine if they met inclusion criteria in the study. For each study the first author, time period, and date of publication were extracted. For populationlevel studies mean age, percentage of females in the cohort, rates of perforation, bleeding, mortality, and percentage of colonoscopies with polypectomy were recorded. Because only a subset of population-level studies reported the indication for colonoscopy (eg, screening, surveillance, or diagnostic), this variable was not included in the meta-regression analysis. For EMR/ ESD studies mean age, percentage of females in the cohort, location of the study (East Asian or Other), rate of perforation, rate of delayed bleeding, and mean polyp size (in mm) was recorded. Delayed bleeding was defined as any clinically significant bleeding that occurred after completion of the procedure up to 30 days postprocedure. Intraprocedural bleeding was not recorded as a separate outcome given the heterogeneity in definition and because almost all cases of reported intraprocedural bleeding were controlled endoscopically during the procedure.
Statistical analysis
A random-effects model was used to calculate the pooled perforation and bleeding rate for both population-level and EMR/ESD studies. Pooled estimates were reported with 95% CIs. Covariates analyzed in regression analysis included mean population age, percentage of females in the cohort, and percentage of polypectomies in the cohort for population-level studies. Covariates analyzed in regression analysis included mean population age, percentage of females in cohort, and size of polyp in EMR/ESD studies. Pooled rates of perforation and bleeding were calculated and grouped by EMR or ESD status. Heterogeneity between studies was measured using the I 2 statistic. Analysis was performed using Comprehensive Meta-Analysis v 3.3.070 (Englewood, NJ).
POPULATION-LEVEL ESTIMATES OF SERIOUS AEs
Twenty-one population-level studies (11 from North America) reporting the rates of perforation, bleeding, or mortality after colonoscopy were identified (Supplementary Table 1 , available online at www.giejournal.org). From these studies, data were extracted on 10,328,360 patients undergoing colonoscopy, of which 5,464,324 (54%) were women; the mean age of all patients was 62.3 years.
Perforation
Colonic perforation during colonoscopy may result from mechanical forces against the bowel wall, barotrauma, or a direct result of therapeutic procedures. Early symptoms include persistent abdominal pain and abdominal distention. Colonic perforation can be intraperitoneal or extraperitoneal. Intraperitoneal perforation leads to leak of air and colonic contents into the peritoneum. Plain radiographs of the chest and abdomen may demonstrate free air, although CT is superior to an upright chest film. 7 Therefore, an abdominal CT should be considered for patients with an unrevealing plain film in whom there is a high suspicion of perforation. 4 Rarely, colonic perforation can be extraperitoneal, leading to the passage of air into the retroperitoneal space, which can then diffuse along the fascial planes and large vessels, causing pneumo-retroperitoneum, pneumo-mediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema. Such patients can have an atypical presentation, including subcutaneous crepitus, neck swelling, chest pain, and shortness of breath after colonoscopy. 8 The pooled rate of perforations among 10,328,360 colonoscopies was 5.8 per 10,000 colonoscopies (95% CI, 5.7-6.0) ( Fig. 1A) . Reported population-level perforation rates ranged from a low of 1.6 per 10,000 to a high of 11.9 per 10,000 with significant heterogeneity between studies (I 2 Z 97.6%). This heterogeneity in studies may reflect differences in indication, population age, comorbidity, geographic location, and rates of polypectomy between studies. In a meta-regression analysis ( Supplementary  Fig. 1A , available online at www.giejournal.org), neither age nor gender was significantly associated with perforation rate. Moreover, after adjusting for differences in age and gender between different population-level studies, polypectomy was not significantly associated with risk for perforation (P Z .9). A previous meta-analysis of population-level studies found a trend toward higher rate of perforation in colonoscopies with polypectomy (8 per 10,000) compared with those without polypectomy (4 per 10,000, P Z .07). 9 These data suggest that a substantial proportion of the risks of perforation from colonoscopy are related to procedural characteristics independent of the performance of polypectomy, such as the amount of torque or pressure applied to the bowel wall during advancement of the colonoscope or barotrauma from insufflation of the colon. Notably, as discussed later in this article, performance of advanced mucosal resection techniques (EMR and ESD) increases the risk for perforation; however, on a population level, the numbers of these advanced procedures as a percentage of all polypectomies are small. These risk estimates therefore likely accurately reflect the risk that most average-risk patients face when undergoing an examination for screening or surveillance purposes.
Certain populations may face higher risks for perforation during colonoscopy, including patients with diverticulosis and inflammatory bowel disease (IBD). 1, [10] [11] [12] [13] Mukewar et al 14 found that patients with IBD undergoing colonoscopy were at an 8-fold higher risk for endoscopyassociated perforations compared with patients without IBD (18.91 per 10,000 procedures vs 2.5 per 10,000 procedures). The use of corticosteroids is associated with a 13-fold greater risk for perforation associated with colonoscopy. Certain comorbid conditions also increase the risk for AEs. In a study of U.S. Medicare beneficiaries, Warren et al 15 found that the presence of stroke, chronic obstructive pulmonary disease, atrial fibrillation, and congestive heart failure all significantly increased the risk of AEs due to colonoscopy. In addition to patient factors, provider factors may also influence the procedure risk. Ranasinghe et al 16 found significant variation (median, 12.3/1000; 5th to 95th percentile, 10.5 to 14.6/1000) in rates of AEs after outpatient colonoscopy between both hospital outpatient departments and free-standing ambulatory surgery centers, which could not be explained by case mix alone, raising the possibility that provider experience could be contributing to the variations in rates of AEs. Using administrative data from several large Canadian provinces, Rabeneck et al 17 found that endoscopists performing at volumes in the lowest quintile (<141 colonoscopies per year) had a 2.96 increase in odds of either perforation or bleeding compared with endoscopists performing at volumes in the highest quintile (>379 colonoscopies per year). In addition, Bielawska et al 10 reported that colonoscopies performed by surgeons and endoscopists of unknown specialty had higher perforation rates when compared with gastroenterologists (odds ratio, 2.00; 95% CI, 1.30-3.08).
Bleeding
Unlike perforation, risk for bleeding during colonoscopy appears to be strongly associated with the performance of polypectomy. Postpolypectomy hemorrhage may occur immediately or can be delayed for up to 4 weeks after the procedure. In our systematic review, the rate of bleeding based on 15 population-level studies, including 5,544,454 patients, was 2.4 per 1000 colonoscopies (95% CI, 2.4-2.5) ( Fig. 1B) . In a meta-regression analysis ( Supplementary Fig. 1B , available online at www. giejournal.org), the percentage of colonoscopies involving a polypectomy strongly predicted rates of bleeding, with a 2.7% increase in risk of bleeding for every 1% increase in rate of polypectomy (P < .001). This association remained significant after adjustment for age and gender (P Z .016). The association between performance of polypectomy and risk for bleeding was also observed by Reumkens et al, 9 with findings of significantly more bleeding events after colonoscopies with polypectomy (9.8/1000) compared with colonoscopies without polypectomy (.6/1000, P < .001).
Polyp size has been reported as a risk factor for postpolypectomy bleeding in several studies. [18] [19] [20] Additional risk factors may include the number of polyps removed, 21, 22 recent warfarin therapy, 20, 23, 24 right-sided colon segment location, 25, 26 and polyp histology. 18 Patient comorbidities, such as cardiovascular disease, 18, 20 may increase the risk for bleeding but also may be a marker for antithrombotic use. 24 Recommendations for the management of antithrombotic therapy in the periendoscopic period are discussed in detail in an ASGE guideline. 27 The prophylactic use of mechanical methods, such as clips or detachable snares, is commonly performed in practice; however, their efficacy in preventing delayed bleeding after non-EMR polypectomies has not been confirmed. Prospective, randomized studies and a metaanalysis have shown prophylactic clipping for polyps <2 cm does not prevent delayed bleeding, [28] [29] [30] but in case of nonpedunculated polyps >2 cm, endoscopic clip closure of the mucosal defect has been demonstrated to reduce the incidence of delayed bleeding events in the proximal colon after resection (see Serious AEs Related to Advanced Resection Techniques, Postprocedural bleeding). Injection of epinephrine before polypectomy was reported to reduce the incidence of intraprocedural bleeding, although there was no demonstrated effect on delayed bleeding. 31, 32 Mortality Death after colonoscopy has been rarely reported. In a 2010 review of AEs based on prospective studies and retrospective analyses of large clinical or administrative databases, 128 deaths were reported among 371,099 colonoscopies, for an unweighted pooled death rate of .03%, or 3 in 10,000 colonoscopies 33 ; all-cause mortality within 30 days occurred in .07% of patients, whereas colonoscopy-specific mortality occurred in .007% of patients. Our systematic review and meta-analysis included only colonoscopy-specific mortality, which was defined as death that could be directly attributable to a postprocedural AE (such as perforation) or the management of a postprocedural AE (such as surgery for a perforation). Nine studies reported colonoscopy-associated mortality rates. Thirty-six deaths occurred among 1,152,158 colonoscopies, for a pooled death rate of .003%, or 3 in 100,000 colonoscopies (Fig. 1C ). Because of the small number of population-level studies reporting mortality data, meta-regression was not performed for the endpoint of mortality. Of the studies that reported both all-cause and colonoscopy-specific mortality, most deaths within 30 days of colonoscopy were not attributable to postcolonoscopy AEs but rather to underlying comorbidities such as cardiopulmonary disease, cirrhosis, and neurologic diseases. Most causes of death directly attributable to colonoscopy were either cardiopulmonary events that occurred during or immediately after the procedure or sequelae of bowel perforation.
SERIOUS AEs RELATED TO ADVANCED RESECTION TECHNIQUES
With enhancements in endoscopic technology, the role of the endoscopist has expanded to removal of large benign polyps and polyps harboring early cancers using advanced techniques such as EMR and ESD. As with standard polypectomy, bleeding and perforation are the most common AEs with EMR and ESD, but they occur more frequently with these advanced techniques. The reported AE rates vary. Lesion size, location, and histology and operator experience may all contribute to this variability. [36] [37] [38] We systematically analyzed the rates of the major endpoints of perforation and bleeding after both EMR of polyps !20 mm in size and ESD while also controlling for covariates of age, gender, location of the study, and polyp size. Rates of AEs were analyzed separately for EMR and ESD. Our search strategy yielded 29 studies, including 8237 unique procedures (Supplementary Table 2 , available online at www.giejournal.org). Of the studies, 14 were reported from East Asia and 15 from either North America, Europe, or Oceania (Western).
Perforation
Twenty studies included in this analysis reported data on perforation rate after EMR. Of 6529 procedures, 59 were complicated by a perforation for a pooled rate of 1.1% (95% CI, .9%-1.4%) ( Fig. 2A ). There was substantial heterogeneity between studies (I 2 Z 83%), with reported rates ranging from .1% to 2.2%. Reasons for this heterogeneity include differences in definition of perforation, differences in polyp size and shape, center experience, and time period of study. Mortality appeared to be low, as no series reported fatalities as sequelae of perforation. Perforation is a term that may incorporate a spectrum of levels of deep mural injury; some have proposed a grading system for levels of mural injury ranging from muscularis propria exposure to fullthickness injury with a visualized hole and observed contamination. 34 Although delayed perforation can occur, most cases of perforation captured in this review were immediately apparent to the endoscopist. The "target sign," which represents concentric resection of progressively deeper layers of mural tissue and appears on the transected surface of the polypectomy specimen as a white to gray circular disk (the "target") surrounded by a web of submucosal tissue that is then encircled by the white cauterized mucosa ( Fig. 3 ), has been suggested as an early marker of perforation that can be visualized endoscopically. 35 It represents a sign of muscle injury that can be either a full-thickness perforation or a partial muscle injury.
Twelve studies reported data on perforation after ESD, and the rate of perforation after ESD was nearly 7fold higher than after EMR, with a pooled rate of 7.2% (103/1708 procedures; 95% CI, 6.0%-8.7%) ( Fig. 2A) ; importantly, however, no fatalities from perforation were reported from these studies. Because perforation is frequently encountered by endoscopists performing colonic ESD, prompt recognition of muscularis propria tissue along the dissection plane is essential. Most series captured in this meta-analysis reported that immediate perforations could usually be closed by deployment of endoscopic clips with very few patients requiring surgery. [36] [37] [38] [39] Meta-regression was performed analyzing factors predicting perforation from advanced resection techniques (Supplementary Fig. 2A , available online at www. giejournal.org), pooling both EMR and ESD. The strongest and only predictor of perforation was the performance of ESD (as compared with EMR). In the subgroup of studies that reported perforation after both EMR and ESD, rates of perforation after ESD were between 5-and 8-fold higher compared with EMR. 36, 40, 41 The mean size of the polyps removed, location of study, and study date were not associated with risk of perforation.
Postprocedural bleeding
Because intraprocedural bleeding prompts immediate therapy and because all advanced tissue removal techniques are usually associated with some degree of intraprocedural bleeding, we only included rates of postprocedural bleeding in our systematic review. We found 27 studies that reported delayed bleeding rates after EMR (19 studies) and ESD (11 studies) (with a follow-up period of up to 30 days after colonoscopy), with a pooled rate of 3.7% (95% CI, 3.2%-4.2%) ( Fig. 2B ) and a range of .2% to 8.4%. As with perforation, substantial heterogeneity was noted (I 2 Z 66%). Unlike perforation, however, the rate of delayed bleeding was not statistically higher after ESD. Of the 11 studies reporting on rates of delayed bleeding after ESD (8 Asian and 3 Western), we found a pooled rate of 2.2% (95% CI, 1.5%-3.0%). By contrast, the EMR cohort experienced a pooled delayed bleeding rate of 4.0% (95% CI, 3.5%-4.5%). In a meta-regression analysis ( Supplementary Fig. 2B , available online at www. giejournal.org), ESD was not associated with higher postprocedural bleeding rates compared with EMR. Polyp size, location, and year of study (temporal trend analysis) were also not associated with higher rate of delayed bleeding. The overwhelming majority of reported bleeding episodes were treated conservatively (blood transfusions, close observation with spontaneous resolution) or with endoscopic therapy. No fatalities from bleeding were reported. Other studies have reported that the following factors are associated with an increased risk for delayed bleeding: right-sided colon location, use of electrosurgical current not controlled by a microprocessor, intraprocedural bleeding at the time of polyp removal, exposed vessels of the post-EMR ulcer, signs of coagulation injury to the resection bed, and use of anticoagulants. 22, [42] [43] [44] The intraprocedural bleeding rate in the literature is over 10% in several large series, with delayed bleeding reported in 1.5% to 14% of cases. 45, 46 In their large case series of 479 large sessile polyps that underwent EMR, Moss et al 47 reported the following rates of AEs: hospitalization, 7.7%; postprocedural pain, 2.1%; serositis, 1.5%; bleeding (mostly immediate), 2.9%; and perforation, 1.3%. There were no deaths. Others have reported rates of immediate and delayed bleeding of 11% and 7%, respectively. 48 Immediate bleeding can be treated with endoscopic therapy during the procedure but adds to procedure time. Most clinical bleeding AEs stop without intervention, although the need for transfusions has been reported. 49 Previous studies on prophylactic hemoclip placement for minimizing risk of postpolypectomy bleeding in patients not on anticoagulation have not shown a reduction in bleeding rates. 30, 50 However, recent data from a randomized controlled trial demonstrated that endoscopic clip closure of the mucosal defect after resection of large colon polyps (!20 mm) reduces the risk of postpolypectomy bleeding (3.5% for the clip group vs 7.1% for the control group; absolute risk difference, 3.6%; 95% CI, .7-6.5), an effect that appeared to be restricted to large polyps in the proximal colon (3.3% in the clip group vs 9.6% in the control group; absolute risk difference, 6.3%; 95% CI, 2.5-10.1. 51 Prophylactic clipping postresection of polyps <20 mm in size has not been shown to reduce the risk of postpolypectomy bleeding. 29 
OTHER AEs RELATED TO COLONOSCOPY
In this section we provide a narrative review of other AEs related to colonoscopy.
Postpolypectomy electrocoagulation syndrome
Postpolypectomy electrocoagulation syndrome (PPES) is the result of electrocoagulation-induced thermal injury during standard polypectomy, EMR, or ESD to the bowel wall that causes a transmural burn and localized peritonitis without evidence of frank perforation on radiographic studies. Typically, patients with PPES present 1 to 5 days after colonoscopy with fever, localized abdominal pain, localized peritoneal signs, and leukocytosis without any radiologic evidence of perforation. The reported incidence varies widely, from 1 in 100 (1%) to 3 per 100,000 (.003%). 2, 33, 52, 53 The incidence is higher (7%-8%) in patients undergoing ESD. 54 PPES usually is managed with intravenous hydration, broad-spectrum parenteral antibiotics, bowel rest, and nothing by mouth until symptoms subside. 2, 53 In a large multicenter study, hypertension, large lesion size (>2 cm), and nonpolypoid morphology were found to be independent predictors of PPES. Thirty-four patients had PPES in this study, with 2.9% of patients requiring intensive care unit stay and no mortality. 53 Full-thickness burns may result in bowel necrosis and delayed perforation, thereby requiring surgical management. Removal of right-sided lesions is likely to be associated with a higher risk of wall injury because of the thinner colonic wall. 55 Submucosal injection of saline solution and other lifting agents are frequently performed to minimize the risk of PPES during endoscopic removal of large polyps. 55, 56 Other techniques reported to decrease the risk of PPES include tenting the polyp away from the colonic wall before applying electrocautery, cutting the stalk of pedunculated polyps one-half or one-third of the distance from the base of the pedicle, and suctioning air out of the colon, especially in the right-sided colon segment, to minimize tension on the wall and increase colonic wall thickness. 57 
Abdominal discomfort and/or bloating
Postcolonoscopy abdominal pain can be because of a host of serious AEs as discussed above; however, abdominal discomfort and/or bloating is a less severe but very common AE postcolonoscopy and can affect patient compliance with future colonoscopies. 33, 58 The discomfort may be caused by colonic spasm, gaseous distention of the colon, and mechanical or barotrauma. The most commonly reported minor AEs of colonoscopy are bloating (2.6%-25%) and abdominal pain and/or discomfort (2.5%-11%). [58] [59] [60] [61] Appropriate techniques, such as avoiding and reducing endoscope looping and minimizing air insufflation, should help reduce these symptoms. 62 In addition, a systematic review and meta-analysis of randomized controlled trials demonstrated less postprocedure pain with carbon dioxide compared with standard air insufflation. 63 Water immersion and water exchange (WE) techniques that avoid air insufflation also may reduce pain, especially when minimal or no sedation is used. A meta-analysis and systematic review comparing air insufflation and water-aided methods (water immersion and WE) for procedure-related pain revealed both water immersion and WE to be superior to air insufflation. 64 Studies comparing water-aided colonoscopy with CO 2 insufflation have reported water immersion and WE significantly reduced colonoscopy insertion pain, and WE was the least painful technique but was the most time consuming. 65, 66 Postcolonoscopy abdominal discomfort because of gaseous distention is usually self-limited and rarely requires hospitalization.
Gas explosion
Explosive AEs from colonoscopy are rare but have serious consequences. 4 A 2007 review reported 9 cases, each resulting in colonic perforation and in 1 case, death. 67 Gas explosion can occur when combustible levels of hydrogen or methane gas are present in the colonic lumen, oxygen is present, and electrosurgical energy is used (eg, electrocautery or argon plasma coagulation). Suspected risk factors are use of nonabsorbable or incompletely absorbable carbohydrate preparations, such as mannitol, lactulose, or sorbitol, 68, 69 and incomplete colonic cleansing either because a sigmoidoscopy preparation was used (eg, enemas) or because of inadequate colonoscopic preparation. 70 Some authors have advocated use of CO 2 during colonoscopy and avoiding enema-only bowel prep before applying argon plasma coagulation for treatment of radiation proctitis. 71 Bowel preps such as polyethylene glycol and sodium phosphate are reportedly safer before use of electrocautery and argon plasma coagulation because they do not result in combustible levels of hydrogen and methane.
Infection
Transient bacteremia after colonoscopy, with or with polypectomy, causing bacterial translocation of normal colonic flora to the bloodstream can occur in approximately 4% of procedures, with a range of 0% to 25%. 72 However, signs or symptoms of infection are rare. Bacteremia is uncommon (6.3%) even after therapeutic colon procedures such as colonic stent insertion. 73 Although individual cases of infection after colonoscopy have been reported, there is no definite causal link with the endoscopic procedure and no proven benefit for antibiotic prophylaxis. 74 Therefore, current guidelines from the American Heart Association and ASGE recommend against antibiotic prophylaxis for patients undergoing colonoscopy. 75 The 2016 update of the multisociety guideline on reprocessing flexible GI endoscopes reported cases of transmission of infection resulting from defective equipment and/or failure to adhere to reprocessing guidelines. 76 Pneumonia and perirectal abscess have been reported after colonoscopy. 77 Pneumonia is mostly because of aspiration related to sedation and less commonly directly related to the procedure, as discussed in detail below in Sedation-related AEs.
Splenic injury
Splenic injury is a rare but serious AE of colonoscopy. It can develop immediately or up to several days after the procedure, making diagnosis difficult. The true incidence is unknown because of variability in reporting, but the reported rates from large series are 1 in 10,000 to 4.5 per 10,000 colonoscopies. 78, 79 These patients are usually women (71.5%) in their sixth decade. 79 A high degree of suspicion is necessary because the clinical presentation can be nonspecific and variable in timing. Because of the high morbidity and mortality (up to 5%) associated with this entity, early identification and treatment are critical. Suggested mechanisms that may cause splenic injury during colonoscopy include direct trauma as the colonoscope traverses the splenic flexure of colon or rupture of the splenic capsule because of traction on the splenocolic ligament or adhesions. Suggested risk factors for splenic injury can be divided into patient-related and procedure-related factors. Suggested patient-related risk factors for splenic injury include prior abdominal surgery, presence of splenocolic adhesions, splenomegaly, endometriosis, inflammation (diverticular disease, IBD, pancreatitis), infection (malaria, typhoid, Epstein-Barr virus-induced infectious mononucleosis), and anticoagulant use. 79, 80 Proposed procedure-related risk factors include difficult colonoscopy, deep sedation with propofol, operator inexperience, supine position, maneuvers such as hooking the splenic flexure to straighten the colon, "slide by" technique and alpha maneuver, and applying abdominal pressure in the left hypochondrium. The splenic injury can be intraparenchymal, subcapsular, or with intraperitoneal extension.
There are 5 grades of splenic injury based on severity (Table 1) . 81 Clinical presentation can vary, and the patient may present with nonspecific abdominal discomfort or abdominal pain that can be diffuse or localized to the left upper quadrant of the abdomen or left shoulder pain (Kehr's sign) occurring within 24 hours of the procedure or, less commonly, delayed by days. Rarely, patients present with hemodynamic shock. Laboratory tests can reveal anemia. The criterion standard for diagnosis is contrast-enhanced CT of the abdomen that enables evaluation of the grade and extent of the splenic injury. US can be useful in assessing splenic injury in patients with hemodynamic instability and for those with contraindication to contrast-enhanced CT (allergy, renal insufficiency, etc). Management options include a conservative approach, splenic artery embolization, and surgery. The treatment option chosen is based on the presentation, underlying comorbidities, and imaging findings. Hemodynamically stable patients can be managed conservatively with close monitoring, intravenous fluids, blood transfusion, and antibiotics. However, some patients may fail a conservative approach and require surgery or splenic artery embolization. For hemodynamically stable patients with grades I to IV lacerations and no history of splenic disease, embolization of the splenic artery has been reported to be an effective therapeutic option. 82 Splenectomy is usually reserved for cases with active bleeding and hemodynamic instability.
Sedation-related AEs
In hospital-and population-based studies, the incidence of aspiration events requiring hospitalization after colonoscopy with moderate or deep sedation is generally low ( 1 in 1000). In a population-based study, the incidence of aspiration requiring hospitalization during 165,527 outpatient diagnostic colonoscopies in 100,359 Medicare patients age 66 years and older (mean age, 76 years) was .14% for patients having colonoscopy under deep sedation with anesthesia assistance and .10% for patients under moderate sedation without anesthesia assistance (P Z .02). 83 A study of 23,508 outpatient colonoscopies at 3 hospitals in Australia reported 1 case (.004%) of aspiration requiring hospitalization in a patient undergoing colonoscopy with general anesthesia. 84 A study of 3155 colonoscopies performed with patients under sedation managed by an anesthesiologist in adults at a single hospital in Italy reported that .16% of patients undergoing colonoscopy had an aspiration requiring "some intervention by an anesthesiologist." 85 Aspiration requiring hospitalizations was not reported. Others have investigated the risk of colonoscopy-associated aspiration using monitored anesthesia care/anesthesia assistance, with mixed results. Wernli et al 86 did not find an increased risk of aspiration pneumonia between anesthesia-assisted colonoscopy and standard sedation (odds ratio, 1.03; 95% CI, 1.00-1.06). However, their study population was limited to patients aged 40 to 64 years. A recent population-based cohort study of 3,059,045 outpatient colonoscopies, of which 862,817 were anesthesia assisted, reported that use of anesthesia assistance was associated with an increased risk of aspiration pneumonia (odds ratio, 1.63; 95% CI, 1.11-2.37) compared with colonoscopies performed without anesthesia assistance. 78 It is commonly believed that aspiration risk is related to duration of nothing by mouth status before colonoscopy. A recent systematic review and meta-analysis 87 found 6 studies (4 randomized controlled trials and 2 observational studies; sample size ranging from 115 to 1345) that reported risk of aspiration based on different durations of nothing by mouth status. [88] [89] [90] [91] [92] [93] In 5 studies no aspirations occurred during colonoscopy and none was reported within 30 days after colonoscopy. [88] [89] [90] [91] 93 In 4 studies bowel preparation was completed at least 2 to 4 hours before colonoscopy. Overall, this systematic review found low-grade evidence that risk of aspiration is not related to duration of nothing by mouth status beyond 2 hours. Similarly, consumption of split-dose bowel prep within 3 to 4 hours of propofol sedation has not shown to increase risk of aspiration. 94 
AEs IN THE PEDIATRIC POPULATION
Overall rates of AEs from pediatric colonoscopy are uncommon, occurring in 1.1% to 2.4% of cases. Data collected prospectively from the Pediatric Endoscopy Database System-Clinical Outcomes Research Initiative (PEDS-CORI), a pediatric component of CORI, on 7792 colonoscopies reported 88 cases with at least 1 serious AE (1.1%). 95 From this database the most common AE was bleeding, occurring in .38% of cases. During colonoscopy, 71% of bleeding occurred in children under 10 years of age. Of 348 patients undergoing polypectomy, 5 (1.4%) had clinically significant bleeding. Hypoxemia was reported in 25% of those with an AE, with more cases using moderate sedation compared with general anesthesia (P < .001). Perforation during colonoscopy has been reported in several large series. [95] [96] [97] [98] Kramer and Narkewicz 96 reported a perforation rate of 3.1% during polypectomy but none during diagnostic colonoscopy. PEDS-CORI reported a single case (.1%) of perforation in a patient with active IBD. Similarly, in a retrospective single-center study based on surgical records, 3 colonoscopy-related perforations occurred out of 3269 procedures (.09%). 96 All perforations were recognized within 24 hours, including 1 intraprocedure, and all were operatively repaired. In another large retrospective study based on physician recall of 7100 patients, 2 perforations occurred, both in patients with IBD: 1 was recognized periprocedure and the other 3 days postprocedure. 97 Several case reports also describe an increased risk of perforation in patients with Ehlers-Danlos type 4, because these patients may also have spontaneous perforation. 99, 100 One of the limitations of PEDS-CORI is that it predominantly reflects intraprocedure information and likely underestimates postprocedural events. A single-center prospective observational study of 9577 procedures (1819 diagnostic colonoscopies) with designated AE terminology tracked pediatric patients within 72 hours of an endoscopic procedure. 96 The authors identified an AE rate of 2.4% (with a minimum of referral to an emergency department) and a polypectomy AE rate of 10.9%, taking into account events beyond the immediate postprocedure threshold. This disproportionate rate likely reflects a bias in children toward increased evaluation when there is a concern for a postprocedure AE. Bleeding risk and serious infection rates were .11% and .07%, respectively; however, data included both upper and lower endoscopic procedures. This study also provided more global AE rates rather than procedure-specific rates.
At least in children under 3 years of age, there is a potential neurocognitive risk for prolonged and repeated procedures. 101 Thus, prolonged, incomplete, or nondiagnostic studies necessitating additional procedures may have longer term effects beyond standard 24-hour or 30-day AE rate statistics. Pediatric-specific colonoscopy quality indicators (eg, bowel preparation quality and ileal intubation rates) may indirectly assess these risks beyond costs, patient inconvenience, and other factors compared with adult patients. [102] [103] [104] Taken together, overall rates of AEs during pediatric colonoscopy are uncommon (1.1%-2.4%) and most often associated with polypectomy. As in adults, significant AEs include bleeding and perforation (.02%-.1%). Pediatric patients with IBD and those with polyps may also be at higher risk of AEs. Research gaps include standardizing AE definitions in pediatric patients and assessing disease-specific risks, the relationship of AEs to pediatric quality indicators, and the role of postprocedural bleeding and closure techniques.
OTHER RARE AEs RELATED TO COLONOSCOPY
Other rare AEs associated with colonoscopy and interventions, such as acute appendicitis and acute diverticulitis, are summarized in the Supplementary Text (available online at www.giejournal.org).
CONCLUSION
Colonoscopy is the most commonly performed endoscopic procedure, and AEs are inherent to its performance. This document provides evidence-based estimates of AEs related to colonoscopy based on population-based studies, AEs related to advanced mucosal resection techniques (EMR and ESD), and a narrative update on other AEs associated with colonoscopy. Even though significant heterogeneity was seen in several analyses, the overall estimates of AEs have remained stable. Because endoscopy has assumed a more therapeutic role in the management of various colonic disorders, the potential for AEs increases. Improved knowledge of potential endoscopic AEs, their expected frequency, and the risk factors associated with their occurrence may help to minimize the incidence by careful selection of measures to help mitigate the risks associated with colonoscopy and other specific colonoscopic interventions [4 Endoscopists are expected to carefully select patients for the appropriate intervention, be familiar with the planned procedure and available technology, and be prepared to manage any AE that may arise. Early recognition and prompt intervention are essential as soon as an AE occurs to help minimize associated morbidity and mortality. Tracking and monitoring AEs as part of a continuing quality improvement process may serve to educate endoscopists, help to reduce the risk of future AEs, and improve the overall quality of colonoscopy. Also, centralized reporting of AEs in the future may help in the development of a robust database, allowing for a better understanding of the true estimates of AEs and thereby serve for safety and quality targets in colonoscopy practice. One early bleed (10 hours postprocedure) and delayed bleed (36 hours postprocedure) were observed. All bleeds (including procedural bleeding) were treated endoscopicallyclips (4), injection (7) , and APC (4 
APPENDIX 1. SEARCH STRATEGY FOR POPULATION-LEVEL STUDIES
Goodness of fit: Test that unexplained variance is zero
Comparison of Model 1 with the null model
Total between-study variance (intercept only)
Proportion of total between-study variance explained by Model 1 Q = 15.81, df = 3, p = .0012 B Tau 2 = 0.2338, Tau = 0.4836, I 2 = 98.85%, Q =780.63, df =9, p = .0000 Tau 2 = 0.3099, Tau = 0.5567, I 2 = 99.49%, Q =2360.26, df =12, p = .0000 R 2 analog = 0.25
Number of studies in the analysis 13
Supplementary Figure 1 . 
Comparison of Model 1 with the null model
Total between-study variance (intercept only)
Proportion of total between-study variance explained by Model 1 R 2 analog = 0.15 
Number of studies in the analysis 29
